1. Ganem D (2007) Kaposi's sarcoma-associated herpesvirus. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins. pp. 2847–2888.
2. HadinotoV, ShapiroM, SunCC, Thorley-LawsonDA (2009) The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output. PLoS Pathog 5: e1000496.
3. HoshinoY, KatanoH, ZouP, HohmanP, MarquesA, et al. (2009) Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. J Virol 83: 11857–11861.
4. MaSD, HegdeS, YoungKH, SullivanR, RajeshD, et al. (2011) A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85: 165–177.
5. MaSD, YuX, MertzJE, GumperzJE, ReinheimE, et al. (2012) An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model. J Virol 86: 7976–7987.
6. StaskusKA, SunR, MillerG, RaczP, JaslowskiA, et al. (1999) Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8†Involvement in Kaposi's Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman's Disease. J Virol 73: 4181–4187.
7. MoorePS, BoshoffC, WeissRA, ChangY (1996) Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274: 1739–1744.
8. CesarmanE, MesriEA, GershengornMC (2000) Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J Exp Med 191: 417–422.
9. MartinDF, KuppermannBD, WolitzRA, PalestineAG, LiH, et al. (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340: 1063–1070.
10. AmelioAL, McAnanyPK, BloomDC (2006) A Chromatin Insulator-Like Element in the Herpes Simplex Virus Type 1 Latency-Associated Transcript Region Binds CCCTC-Binding Factor and Displays Enhancer-Blocking and Silencing Activities. J Virol 80: 2358–2368.
11. HoldorfMM, CooperSB, YamamotoKR, MirandaJJ (2011) Occupancy of chromatin organizers in the Epstein-Barr virus genome. Virology 415: 1–5.
12. KangH, WiedmerA, YuanY, RobertsonE, LiebermanPM (2011) Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog 7: e1002140.
13. TemperaI, LiebermanPM (2010) Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 1799: 236–245.
14. GauseM, SchaafCA, DorsettD (2008) Cohesin and CTCF: cooperating to control chromosome conformation? BioEssays 30: 715–718.
15. PhillipsJE, CorcesVG (2009) CTCF: master weaver of the genome. Cell 137: 1194–1211.
16. KimTH, AbdullaevZK, SmithAD, ChingKA, LoukinovDI, et al. (2007) Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128: 1231–1245.
17. WanLB, PanH, HannenhalliS, ChengY, MaJ, et al. (2008) Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development. Development 135: 2729–2738.
18. XieX, MikkelsenTS, GnirkeA, Lindblad-TohK, KellisM, et al. (2007) Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci U S A 104: 7145–7150.
19. FilippovaGN, FagerlieS, KlenovaEM, MyersC, DehnerY, et al. (1996) An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 16: 2802–2813.
20. BellAC, WestAG, FelsenfeldG (1999) The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98: 387–396.
21. CuddapahS, JothiR, SchonesDE, RohTY, CuiK, et al. (2009) Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res 19: 24–32.
22. DorsettD, MerkenschlagerM (2013) Cohesin at active genes: a unifying theme for cohesin and gene expression from model organisms to humans. Curr Opin Cell Biol 25: 327–333.
23. SchaafCA, KwakH, KoenigA, MisulovinZ, GoharaDW, et al. (2013) Genome-wide control of RNA polymerase II activity by cohesin. PLoS Genet 9: e1003382.
24. ChenHS, WikramasingheP, ShoweL, LiebermanPM (2012) Cohesins Repress Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Gene Transcription during Latency. J Virol 86: 9454–9464.
25. KangH, LiebermanPM (2009) Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. J Virol 83: 6199–6210.
26. StedmanW, KangH, LinS, KissilJL, BartolomeiMS, et al. (2008) Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J 27: 654–666.
27. MyoungJ, GanemD (2011) Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174: 12–21.
28. BruloisKF, ChangH, LeeAS, EnsserA, WongLY, et al. (2012) Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86: 9708–9720.
29. AndersS, HuberW (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
30. NixDA, CourdySJ, BoucherKM (2008) Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics 9: 523.
31. ThorvaldsdottirH, RobinsonJT, MesirovJP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14: 178–192.
32. RossettoCC, PariG (2012) KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog 8: e1002680.
33. ZiebarthJD, BhattacharyaA, CuiY (2013) CTCFBSDB 2.0: a database for CTCF-binding sites and genome organization. Nucleic Acids Res 41: D188–D194.
34. SchmidtD, SchwaliePC, Ross-InnesCS, HurtadoA, BrownGD, et al. (2010) A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res 20: 578–588.
35. RubioED, ReissDJ, WelcshPL, DistecheCM, FilippovaGN, et al. (2008) CTCF physically links cohesin to chromatin. Proceedings of the National Academy of Sciences 105: 8309–8314.
36. WendtKS, YoshidaK, ItohT, BandoM, KochB, et al. (2008) Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451: 796–801.
37. BlencoweBJ, AhmadS, LeeLJ (2009) Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev 23: 1379–1386.
38. DorsettD, StromL (2012) The ancient and evolving roles of cohesin in gene expression and DNA repair. Curr Biol 22: R240–250.
39. FayA, MisulovinZ, LiJ, SchaafCA, GauseM, et al. (2011) Cohesin selectively binds and regulates genes with paused RNA polymerase. Curr Biol 21: 1624–1634.
40. RhodesJM, BentleyFK, PrintCG, DorsettD, MisulovinZ, et al. (2010) Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved. Dev Biol 344: 637–649.
41. AmonW, BinneUK, BryantH, JenkinsPJ, KarsteglCE, et al. (2004) Lytic cycle gene regulation of Epstein-Barr virus. J Virol 78: 13460–13469.
42. Mavromara-NazosP, RoizmanB (1987) Activation of herpes simplex virus 1 gamma 2 genes by viral DNA replication. Virology 161: 593–598.
43. ChangJ, GanemD (2000) On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 81: 2039–2047.
44. TothZ, BruloisKF, WongLY, LeeHR, ChungB, et al. (2012) Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol 86: 9696–9707.